Literature DB >> 7430304

An integrated approach to measurements of quinidine and metabolites in biological fluids.

T W Guentert, A Rakhit, R A Upton, S Riegelman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7430304     DOI： 10.1016/s0378-4347(00)81597-2

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  3 in total

1.  Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.

Authors:  S L Bramer; A Suri
Journal:  Clin Pharmacokinet       Date:  1999       Impact factor: 6.447

2.  Isolation, characterisation and synthesis of a new quinidine metabolite.

Authors:  T W Guentert; J J Daly; S Riegelman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982 Jan-Mar       Impact factor: 2.441

3.  Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.

Authors:  A Rakhit; T W Guentert; N H Holford; J Verhoeven; S Riegelman
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.